Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 189 entries
View as:

A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02125435 Org: User:
Start: 01/31/11 End: 05/31/12 Due: 05/31/13

A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor

Phase: N/A Priority: Normal
NCT ID: NCT01974206 Org: User:
Start: 11/20/13 End: 11/05/20 Due: 11/05/21

A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Phase: N/A Priority: Normal
NCT ID: NCT04225117 Org: User:
Start: 03/09/20 End: 09/30/26 Due: 09/30/27

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05365581 Org: User:
Start: 06/07/22 End: 06/30/27 Due: 06/30/28

Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06500741 Org: User:
Start: 11/22/24 End: 04/02/25 Due: 04/02/26

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT02960022 Org: User:
Start: 12/22/16 End: 07/31/26 Due: 07/31/27

A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause

Phase: N/A Priority: Normal
NCT ID: NCT06812754 Org: User:
Start: 03/10/25 End: 07/31/26 Due: 07/31/27

A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations

Phase: N/A Priority: Normal
NCT ID: NCT02588261 Org: User:
Start: 02/11/16 End: 12/21/17 Due: 12/21/18

A Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Fidaxomicin in Healthy Male Japanese and Caucasian Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01813448 Org: User:
Start: 02/28/13 End: 04/30/13 Due: 04/30/14

A Study to Learn How [14C]ASP0367 is Processed by the Body in Healthy Men

Phase: N/A Priority: Normal
NCT ID: NCT05217901 Org: User:
Start: 01/21/22 End: 05/09/22 Due: 05/09/23

A Study to Find a Suitable Dose of ASP2802 in People With CD20-positive B-cell Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT06248086 Org: User:
Start: 09/06/24 End: 12/05/24 Due: 12/05/25

A Study to Assess the Effect of Food With Fezolinetant in Healthy Female Participants

Phase: N/A Priority: Normal
NCT ID: NCT04641260 Org: User:
Start: 11/20/20 End: 02/21/21 Due: 02/21/22

A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04094519 Org: User:
Start: 01/27/20 End: 12/27/20 Due: 12/27/21

Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study

Phase: N/A Priority: Normal
NCT ID: NCT05381311 Org: User:
Start: 09/03/21 End: 12/11/22 Due: 12/11/23

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02141425 Org: User:
Start: 03/31/14 End: 04/30/14 Due: 04/30/15

A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02091960 Org: User:
Start: 09/05/14 End: 01/30/24 Due: 01/30/25

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

Phase: N/A Priority: Normal
NCT ID: NCT03364153 Org: User:
Start: 01/12/18 End: 03/31/25 Due: 03/31/26

A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05520567 Org: User:
Start: 01/31/23 End: 07/31/28 Due: 07/31/29

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Phase: N/A Priority: Normal
NCT ID: NCT05014139 Org: User:
Start: 12/07/21 End: 05/31/28 Due: 05/31/29

Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01657890 Org: User:
Start: 06/30/12 End: 01/31/13 Due: 01/31/14

A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01705483 Org: User:
Start: 08/28/12 End: 06/11/14 Due: 06/11/15

A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)

Phase: N/A Priority: Normal
NCT ID: NCT01618669 Org: User:
Start: 06/30/12 End: 12/31/14 Due: 12/31/15

A Study to Assess the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Mycophenolate Mofetil in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01711489 Org: User:
Start: 03/31/12 End: 04/30/12 Due: 04/30/13

A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01585233 Org: User:
Start: 04/30/12 End: 01/07/15 Due: 01/07/16

Incidence and Clinical Burden of Erythropoietin Hyporesponsiveness - a Retrospective Database Analysis

Phase: N/A Priority: Normal
NCT ID: NCT05530291 Org: User:
Start: 11/18/22 End: 11/22/22 Due: 11/22/23